The US Food and Drug Administration (USFDA) has characterized the Alembic Pharmaceuticals General Oral Solid Formulation Facility situated at Panelav as Voluntary Action Indicated (VAI). Assessment at the said Facility was led by USFDA from ninth March, 2020 to thirteenth March, 2020.

VAI implies USFDA acknowledged the Company's reaction to its perceptions.

Portions of ALEMBIC PHARMACEUTICALS LTD. was last exchanging BSE at Rs.745.95 when contrasted with the past close of Rs. 763.1. The all out number of offers exchanged during the day was 17737 in more than 1256 exchanges.

The stock hit an intraday high of Rs. 788 and intraday low of 729.2. The net turnover during the day was Rs. 13411388.